QTRILMET

This brand name is authorized in Estonia, Lithuania, Poland

Active ingredients

The drug QTRILMET contains a combination of these active pharmaceutical ingredients (APIs):

1 Metformin
UNII 786Z46389E - METFORMIN HYDROCHLORIDE

Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.

Read about Metformin
2 Saxagliptin
UNII Z8J84YIX6L - SAXAGLIPTIN HYDROCHLORIDE

Saxagliptin is a highly potent (Ki: 1.3 nM), selective, reversible, competitive, DPP4 inhibitor. Saxagliptin improves glycaemic control by reducing fasting and postprandial glucose concentrations in patients with type 2 diabetes.

Read about Saxagliptin
3 Dapagliflozin
UNII 887K2391VH - DAPAGLIFLOZIN PROPANEDIOL

Dapagliflozin is a highly potent, selective and reversible inhibitor of SGLT2. SGLT2 is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Dapagliflozin improves both fasting and post-prandial plasma glucose levels by reducing renal glucose reabsorption leading to urinary glucose excretion.

Read about Dapagliflozin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A10BD25 A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD25

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1806498, 1806500, 1806511, 1806522, 1806533, 1806544, 1806555, 1806566, 1806577, 1806588
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1088914, 1088915, 1088916, 1088917, 1088918, 1088919, 1088920, 1088921, 1088922, 1088923, 1088924, 1088925, 1088926, 1088927, 1088928, 1088929, 1088930, 1088931, 1088932, 1088933, 1088934, 1088935, 1088936, 1088937, 1088938, 1088940, 1088941, 1088942
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100429898, 100429906

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.